Joint with: Cancer Immunotherapy: Clinical Lessons to New Modalities
Immune Cell Therapies: Advances in Cancer and Autoimmune Disease

Mar 16–19, 2025 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers: Katy Rezvani, Nathan Singh and Stephan Mielke

  In Person
  On Demand

Mar 16–19, 2025 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers: Katy Rezvani, Nathan Singh and Stephan Mielke

Available Formats:   = In Person     = On Demand
Sunday, March 16, 2025
Registration
4:00–8:00 PM
 Van Horne Foyer
Welcome Mixer
6:00–8:00 PM
 Van Horne Foyer
Monday, March 17, 2025
Breakfast
7:00–8:00 AM
 Mezzanine 2
Welcome and Keynote Session (Joint)
8:00–9:30 AM
 Van Horne Ballroom
Carl H. June, University of Pennsylvania
Cell Therapies: Current State-of the Art
Ton N. Schumacher, Netherlands Cancer Institute
Dissecting T Cell Recognition of Cancer
Coffee Break
9:30–9:50 AM
 Van Horne Foyer
Overcoming Challenges in Immune and Cell Therapy: Insights into Mechanisms of Failure and Solutions (Joint)
9:50–11:30 AM
 Van Horne Ballroom
Nathan Singh, Washington University School of Medicine
Genomic Regulation of CAR-Driven T Cell Dysfunction
Shannon J Turley, Genentech, Inc.
CAF Targeting
Anna Christina Obenauf, Research Institute of Molecular Pathology
Rational Combination of Therapies to Stimulate the APC Compartment
May Daher, MD Anderson Cancer Center
Metabolic Interventions to Enhance Adoptive Cellular Therapies
Short Talk(s) Chosen from Abstracts
Poster Setup
11:30–1:00 PM
 Mezzanine 2
On Own for Lunch
11:30–2:30 PM
Poster Viewing
1:00–10:00 PM
 Mezzanine 2
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
 Van Horne B/C
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
 Van Horne Foyer
Cell Therapies for Solid Tumors
5:00–7:00 PM
 Van Horne B/C
Michelle Monje, Stanford University
Targeting Pediatric Brain Cancers
Marcela V. Maus, Harvard Medical School
Driving Complex CAR-T into the Clinic – What, Why, and How
Speaker to be Announced †
Talk Title to be Announced
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
 Mezzanine 2
Posters
7:30–10:00 PM
 Mezzanine 2
Tuesday, March 18, 2025
Breakfast
7:00–8:00 AM
 Mezzanine 2
Diversity, Access and Pathways to Regulatory Approval
8:00–11:00 AM
 Van Horne B/C
Stephan Mielke, Karolinska Institutet
CAR T Cells: A European Perspective
Heather Lombardi, FDA HHS
Regulatory Considerations for Cell Therapies
Jen Chow, Chimeric Therapeutics
Commercially Conscious Development of Cell Therapies
Rayne H. Rouce, Baylor College of Medicine
Improving Access to Cell Therapies
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
 Van Horne Foyer
Poster Setup
11:00–1:00 PM
 Mezzanine 2
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
 Mezzanine 2
Career Roundtable (Joint)
3:00–4:30 PM
 Van Horne B/C
Coffee Available
4:30–5:00 PM
 Van Horne Foyer
Cell Therapy for Autoimmune Diseases
5:00–7:00 PM
 Van Horne B/C
Andreas Mackensen, University Hospital of Erlangen
CAR T Cells for B-cell mediated Autoimmune Disease
Gwendolyn Binder, Cabaletta Bio
Clinical and Translational Development of Engineered T Cell Therapy for Autoimmune Disease
Megan K. Levings, University of British Columbia
CAR Tregs
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
 Mezzanine 2
Posters
7:30–10:00 PM
 Mezzanine 2
Wednesday, March 19, 2025
Breakfast
7:00–8:00 AM
 Mezzanine 2
Alternative Immune Effectors
8:00–11:00 AM
 Van Horne B/C
Katy Rezvani, University of Texas MD Anderson Cancer Center
Engineering NK Cells for Cancer Immunotherapy
Michael Klichinsky, Carisma Therapeutics
CAR-M: Engineering Myeloid Cells ex vivo and in vivo for Cancer Immunotherapy
Bob Valamehr, Fate Therapeutics
iPSCs for Cell Therapy
Jurgen Kuball, University Medical Center
Mastering Diversity of gdT Cells and the Receptors for Cancer Immune Therapies
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
 Van Horne Foyer
On Own for Lunch
11:00–2:30 PM
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
 Van Horne B/C
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
 Van Horne Foyer
Engineering in Cancer Immunotherapy to Enhance Efficacy (Joint)
5:00–6:45 PM
 Van Horne Ballroom
Jaehyuk Choi, Northwestern University
Talk Title to be Announced
Rosandra Natasha Kaplan, NCI, National Institutes of Health
Engineering of Myeloid Cells
Julia Carnevale, University of California, San Francisco
CRISPR-Based T Cell Editing to Enhance Cell Therapy
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers) (Joint)
6:45–7:00 PM
 Van Horne Ballroom
Social Hour with Lite Bites
7:00–8:00 PM
 Mezzanine 2
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Thursday, March 20, 2025
Departure
12:00–11:59 PM

Subscribe for Updates